HROGas03 Cells

The HROGas03 cell line is derived from the gastric adenocarcinoma of an adult female patient. Gastric adenocarcinoma, a common type of stomach cancer, arises from the glandular epithelial cells of the stomach lining and is often associated with poor prognosis. As a model, HROGas03 provides an invaluable resource for studying the molecular pathways involved in the initiation, progression, and therapeutic resistance of gastric adenocarcinoma. The age-related aspects of the donor, such as potential genomic instability and alterations in tumor microenvironment, can provide unique insights into cancer biology in older individuals. This cell line allows researchers to explore key molecular mechanisms driving gastric cancer, such as mutations in tumor suppressor genes (e.g., TP53), alterations in the cell cycle, and dysregulated signaling pathways, including the Wnt, MAPK, and PI3K/AKT pathways. These pathways are often implicated in the survival, proliferation, and metastatic potential of gastric cancer cells. The HROGas03 cell line can also be used to assess the efficacy of targeted therapies, chemotherapeutic agents, or combination treatments, potentially leading to improved therapeutic strategies for gastric cancer patients, especially in older demographics.